Americans Can't Afford Insurance — and Obamacare is to Blame


By Sally C. Pipes

The number of uninsured Americans rose in 2018 for the first time since the Affordable Care Act passed in 2010, according to the Census Bureau.

Obamacare's defenders were quick to blame the change on meddling by the Trump administration. But the real culprit is the law's faulty design.

Since the first exchange plans went into effect in 2014, Obamacare has delivered higher premiums and deductibles for Americans who don't get coverage from their employers. As a result, millions have fled the Obamacare exchanges over the past few years. Today, only people who receive government subsidies can afford exchange plans.

Currently, Americans who make less than 400 percent of the federal poverty level but do not qualify for Medicaid are eligible for subsidies. These subsidies are generous. For example, a family of four with $50,000 in annual income could get a $15,855 plan for just $3,250 -- or $271 per month.

Just under half of Americans are eligible for subsidies. The rest are out of luck, and face monthly premiums routinely exceeding $1,000.

As a result, many people are deciding not to shop for coverage on Obamacare's exchanges. Between 2016 and 2018, unsubsidized enrollment plummeted by 2.5 million -- a 40 percent decline from around 6.2 million to 3.7 million. Eighty seven percent of people with exchange coverage received subsidies in 2019.

The cost of exchange coverage has soared because of Obamacare's many rules, mandates, and regulations. Obamacare requires every plan sold on the exchanges to cover a list of 10 "essential health benefits," from pediatric vision care to substance abuse treatment. Such comprehensive coverage is expensive. It's also unappealing to many people, particularly young folks for whom these benefits seem far from "essential."

Obamacare also forces insurers to charge everyone of a certain age the same rate, regardless of their health status.

These mandates have raised costs for insurers, which they've passed on to enrollees in the form of higher premiums. In 2017, average exchange premiums rose 21 percent. Not surprisingly, exchange enrollment fell by 10 percent that same year. Americans who didn't qualify for subsidies accounted for roughly 85 percent of this decrease.

An additional 1.2 million unsubsidized patients exited the exchanges in 2018, when premiums rose by 26 percent.

Fortunately, there's at least one option still available to those who can't afford the plans on Obamacare's exchanges -- short-term, limited duration insurance. These policies are exempt from Obamacare's mandates. Insurers don't have to cover every essential health benefit and can price plans based on a beneficiary's risk.

As a result, short-term plans are far more affordable. One analysis found that premiums for the cheapest short-term plans are 80 percent lower than those for the least expensive Obamacare plans.

And thanks to a rule change by the Trump administration, Americans can purchase short-term plans that last up to 364 days. Insurers can also renew those policies for up to three years. Previously, short-term plans only lasted three months and couldn't be renewed.

As the next open enrollment period approaches, it's clearer than ever that Obamacare has failed. The law's mandates were supposed to help every American get insurance. Instead, they've made it impossible for almost anyone to purchase coverage without a government subsidy. So much for the "Affordable" Care Act.

Sally C. Pipes is president, CEO, and Thomas W. Smith Fellow in Health Care Policy at the Pacific Research Institute. Her latest book is The False Promise of Single-Payer Health Care (Encounter). Follow her on Twitter @sallypipes. This piece originally ran in Detroit News.

More Resources


04/27/2024
With Trump in Court, Can Biden Take Advantage?
As polls show the race tied, the president is campaigning around the country and his opponent is stuck spending his days in a Manhattan courtroom

more info


04/27/2024
Biden's Outrageous Quest To Jail Trump Before the Election
The Manhattan hush-money case is absurd, unjust and outrageously partisan.

more info


04/27/2024
Navigating Transitions in an Uncertain Economy
Mohamed ElErian explains how to recalibrate expectations in the face of yet another forecasting failure

more info


04/27/2024
PA Could Be 'Ground Zero' for a Novel Presidential Tie
Pennsylvania is the top battleground state that President Joe Biden needs to win to stave off a 2024 loss to Donald Trump or an electoral tie.

more info


04/27/2024
The Most Feared and Least Known Political Operative in U.S.
Susie Wiles, the people who know her the best believe, is a force more sensed than seen. Her influence on political events, to many who know what they're watching, is as obvious as it is invisible. The prints leave not so much as a smudge. It's a shock when she shows up in pictures. Even then it is almost always in the background. She speaks on the record hardly ever, and she speaks about herself even less.

more info


04/27/2024
All the Disinformation That's Fit To Print
Will heavy-handed U.S. intelligence spooks re-elect Trump? Will the New York Times help?

more info


04/27/2024
Arizona Indictments Come at the Worst Time for Trump
The Supreme Court should focus on the crimes Donald Trump's allies are accused of committing when it rules on the

more info


04/27/2024
SCOTUS Hears Trump's Immunity Claim


more info


04/27/2024
Biden's Civil Rights Rollback
Under Trump, college kids accused of sexual assault were given the right to defend themselves. With his update of Title IX, Biden has taken it away.

more info


04/27/2024
House Speaker Mike Jellyfish Flops Again
House Speaker Mike Johnson has gone from zero to Mitch McConnell in record time. The conservative firebrand who was elected last Oct. 25 to lead Republicans to greater glory now resembles his depleted Senate counterpart.

more info


04/27/2024
Ukraine Is Far From Doomed
When comparing Ukraine's situation in 2024 to Europe's in 1941, Russia's defeat seems entirely possible.

more info


04/27/2024
How a Nation Reformed Its Universities
Universities are once again at the center of national debate.

more info


04/27/2024
Why the Israel-Hamas War Has Spun Campuses Into Chaos


more info


04/27/2024
No One Has a Right To Protest at My Home


more info


04/27/2024
The Real Reagan: Getting Beyond the Caricatures


more info



Custom Search

More Politics Articles:

Related Articles

Americans Can't Afford Insurance — and Obamacare is to Blame


The number of uninsured Americans rose in 2018 for the first time since the Affordable Care Act passed in 2010, according to the Census Bureau.

ICER Discriminates Against People with Rare Diseases


FDA officials approved a record number of rare disease treatments last year. One groundbreaking medicine treats an inherited bone condition that causes intense pain and immobility. Another treats Fabry disease, a genetic condition that can lead to kidney failure or stroke.

Minor Legislation with Massive Implications


U.S. Senator Ron Johnson (R-WI) is promoting the "Prevent Government Shutdown Act of 2019." The goal of the act is to prevent disruptive government shutdowns.

When Humans Don't Procreate


The "hook" of the story intrigued me: "This hasn't happened in all of modern history..." An email from "The Crux" last month blared, "Global population growth to virtually stop by 2100."

Beware of Bills in Sheep's Clothing


There is a bipartisan tradition of naming bills such that no reasonable person would oppose them. For instance, changes to our tax system came with the passage of the Tax Cuts and Jobs Act. Who's against jobs? And how could anyone have voted against the Patient Protection and Affordable Care Act (i.e., "Obamacare")?

Offshore Bans Hurt Working Class Americans


Congressional Democrats just betrayed America's working class.

If You Like Your Health Plan, You Can't Keep It Under a Public Option


Nearly two in three Americans support the creation of a government-sponsored health plan to compete against plans offered by private insurers, according to the most recent survey data from the Kaiser Family Foundation.

Don't Legalize Discrimination Against People With Disabilities


Imagine if the federal government treated disabled Americans as second-class citizens. It's an appalling thought. But it could happen soon -- if some special interest groups get their way.

It's Time to Turn the Prescription Drug Debate on its Head


Politicians typically blame drug companies for soaring pharmacy prices. But insurers, pharmacies, and other middlemen are the real driving force behind rising drug spending.

U.S. Carbon Emissions Are Actually Dropping


Increased natural gas consumption helped bring down U.S. greenhouse gas emissions in 2019, according to a recent report from the U.S. Energy Information Administration.

"Buy American" Executive Order Could Slow Delivery of a Coronavirus Cure


President Trump is considering a "Buy American" executive order requiring government agencies to purchase medicines and medical supplies domestically.

Don't Disrupt the Supply Chain in the Midst of a Pandemic


The Trump administration fears America has lost its ability to mass-produce the medicines and medical supplies needed to fight the coronavirus and other, future pandemics. So it's considering an executive order to bring drug and medical-supply manufacturing back to the United States.

Intellectual Property Makes Sure Drug Makers Deliver


House Democrats Peter DeFazio, Rosa DeLauro, Lloyd Doggett, and Jan Schakowsky want to nullify intellectual property rights on any experimental treatments for COVID-19. They believe their proposals will prevent "price gouging and profiteering" without harming innovation.

Move These Projects Forward and Get America Back to Work


With more than 40 million Americans out of a job due to the coronavirus pandemic, states are scrambling to help the unemployed and laying plans to reopen the economy.

COVID-19 Cost-Effectiveness Research Deepens Racial Disparities


A newly released study by the Institute for Clinical and Economic Review (ICER), a Boston-based nonprofit, attempts to answer a weighty question: How much should it cost to treat the coronavirus?